The
increase in occurrences of chronic diseases in Spain has triggered a growth in
biologics market, technological advancements and introduction of new products.
The improvement in efficacy of drug delivery, drug safety along with
controlling the rate of drug delivery, time, and place of drug release in the
body are the major elements affecting the drug delivery technologies. Almost
all the companies are manufacturing smart and fast technologies which offer
effective treatments for diseases. Majority of manufacturing companies are
investing huge funds in the research and development of drug delivery systems
that cater to the needs of patients for effective delivery of drugs.
The
leading players in global drug delivery technology market are Johnson &
Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc.
(U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M
Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc,
(U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.). The applications of
drug delivery devices are at hospitals, ambulatory surgical centers, home care
settings, diagnostic centers, other facilities such as medical data centers,
research and clinical laboratories. Drug Delivery devices are used to
administer medical drugs via Oral, Injectable, Topical, Ocular, Nasal,
Pulmonary, Transmucosal, and Implantable.
The
introduction of central venous catheters (CVCs) in Spain has created healthcare
reforms with a positive impact and safety. It was observed that CVC’s are the
best practices of using and managing invasive devices. CVC’s prevents and
control healthcare-associated infections in hospitals, outpatient settings, and
home healthcare settings along with associated complications. These key factors
led to an increased adoption rate of CVCs in healthcare centres Spain. The
increasing awareness about the antimicrobial technology has led to increasing
adoption of antimicrobial CVCs. The central venous catheters in Spain are
segmented into antimicrobial, non-antimicrobial, and non-tunneled catheter
devices. The non-tunneled CVCs are also known as subclavian, percutaneous, and
short-term catheters which are used as an alternative to peripherally inserted
central catheters (PICC). Healthcares facilitating dialysis procedures for
urological and renal disorders witness an increased influx of patients and a
large requirement of catheterization. The applications of CVC’s are at
multi-specialty hospitals, private hospitals, and hospital groups.
The
leading players in the CVC’s in Spain are Teleflex Inc, C. R. Bard Inc, Edwards
Lifesciences Corp and B. Braun Melsungen AG. The other vendors in central
venous catheters market are Vygon, Cook, Amecath, AngioDynamics, BACTIGUARD,
BD, Biosensors International, Boston Scientific, CONMED, Guangdong Baihe
Medical Technology, Intra special catheters, isomed, Kimal, lepumedical,
Medical Components, PRODIMED, SCW MEDICATH, SILMAG, Smiths Medical, Terumo,
TROGE MEDICAL, TUOREN Medical, VOGT MEDICAL, and ZOLL Medical.
According
to the study “Spain
Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion
Systems, Needle Free Injections and Metered Dose Inhaler Devices”,
large hospitals across the country acquire or merge with medium and small hospitals
to enhancing the quality of treatment. Merging improves the capital investment,
technology, and infrastructure of the small hospitals. Therefore, more
population will prefer quality treatment which in turn demands for infusion
pumps and reduces cost. Also, smaller hospitals under the wings of bigger
hospitals provide complicated treatments and surgeries that involve infusion of
drugs and fluids such as blood and nutrients with the use of infusion pumps.
The infusion pumps market in Spain will witness a steady growth over the coming
years.
The
infusion pumps are manufactured and sold at local and international levels. The
global manufacturers focus on improved technologies, high-quality products, and
brand image. The increasing demand for infusion pumps and accessories such as
injection port, IV cables, syringes, air embolism, infiltration, hematoma, and
dose error will have an adverse impact on the infusion pumps market. The
applications of global infusion pumps are at the ambulatory surgical centers (ASCs),
hospitals, and physician’s offices.
Infusion
pumps are used in healthcare facilities to inject fluid drugs, nutrients, and
blood in a controlled manner. The adoption of infusion pumps in almost all
chronic illnesses and cancer cases is expected rise with modern lifestyle and
is sure to support the growth of infusion pumps market over the coming years.
Spain infusion systems market is segmented into ambulatory infusion pumps,
enteral infusion pumps, implantable infusion pumps, infusion disposable set, syringe
pumps and volumetric pumps. The leading players in Spain’s infusion pumps
market are Hospira Inc, Becton Dickinson and Co, Baxter International Inc and
Medtronic plc. The other vendors in the infusion systems market are Flowonix
Medical, InfuSystem, Moog, Medovex, and Zimmer Biomet.
A
metered-dose inhaler (MDI) is a device used to deliver a specific amount of
medication to the lungs. MDI delivers drug in the form of a short burst of
aerosolized medicine through inhalation. MDI is used to treat asthma, chronic
obstructive pulmonary disease and other respiratory diseases. With the
initiation of macromolecular medications using metered-dose inhaler the scope
of aerosol drug delivery is expanding to other non-respiratory illnesses such
as diabetes, analgesia, thyroid disorders, and other genetic disease. The
leading players in Spain’s metered-dose inhaler market are GlaxoSmithKline Plc,
AstraZeneca Plc and Boehringer Ingelheim GmbH. The MDI market in Spain will
witness a steady growth over the coming years.
Needle
free injection technology (NFIT) includes a wide range of drug delivery
systems. Drugs are administered through skin using any of the forces as
Lorentz, Shock waves, pressure by gas or electrophoresis nullifying the use of
needle. This technology is highly useful in mass immunization programmes. NFIT
devices are classified based on their working, type of load, mechanism of drug
delivery and site of delivery. The sterility, shelf life and viscosity of drug
are the main components for a stable, safe and an effective drug dose through
NFIT. The NFIT market in Spain will witness a steady growth over the coming
years.
The
key factors driving the growth in drug delivery devices market are increased
prevalence of chronic diseases, technological advances, increase in individual
therapy, increased understanding about drug metabolism among the population,
and requirement of controlled drug release. The major challenges faced by
Spain’s drug delivery devices market are injuries, infections, high cost and
strict regulatory framework. The various drug delivery devices in Spain also
include injectable, transdermal, ocular, implantable, oral, nasal, topic and
pulmonary drug delivery devices. The major players in Spain’s drug delivery
devices are INJEX – Equidyne Systems, Teleflex Inc, B. Braun Melsungen AG,
Bioject Medical Technologies Inc, GlaxoSmithKline Plc, Baxter International
Inc, Edwards Lifesciences Corp, Antares Pharma Inc, AstraZeneca Plc, Boehringer
Ingelheim GmbH, Fresenius Kabi AG, Pfizer Inc, Merck & Co Inc, Becton
Dickinson and Co, C. R. Bard Inc, Smiths Medical, Terumo Corp, Teva
Pharmaceutical Industries Ltd, Medtronic Plc and Hospira Inc. Overall, the drug
delivery devices market in Spain is expected to grow steadily over the coming
years.
Key Topics Covered in the Report
Spain
Drug Delivery Devices Market Research
Spain
Drug Delivery Devices Market Size
Infusion
Pumps Market In Spain
Spain
Needle Free Injection Technology
Metered-Dose
Inhaler (MDI) Market in Spain
Needle
Free Injection Technology (NFIT) Market in Spain
Central
Venous Catheters Demand in Spain
Global
Drug Delivery Technology Market Research
Johnson
& Johnson Market Share In Spain
Merck
& Co., Inc Market Share In Spain
For more
information on the market research report please refer to the below link:
Related Reports:
Contact Us:
Ken
Research
Ankur
Gupta, Head Marketing & Communications
0124-4230204